Balyasny Asset Management »

C4 Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.9M 1.9M 4.62
2024-03-31 $20M 2.4M 8.17
2023-12-31 $9.6M 1.7M 5.65
2023-06-30 $32k 12k 2.75

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
BlackRock
OrbiMed Advisors
Soleus Capital Management
Vanguard Group
Commodore Capital
State Street Corporation
Bank of America Corporation
Balyasny Asset Management
Silverarc Capital Management
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics